Search results
UPDATE 2-Evonik expects Q2 core profit in line with Q1, confirms 2024 outlook
Reuters via Yahoo Finance· 6 days agoGerman chemicals group Evonik Industries said on Wednesday it expects its results to be strong in the second quarter, but is keeping its full-year guidance unchanged due to ongoing uncertainty ...
Being vaccinated against COVID-19 reduces the severity of the illness
Digital Journal· 5 days agoA new study reveals how COVID-19 vaccines prevent severe disease. This is based on research...
AstraZeneca pulls its COVID-19 vaccine from the European market
Atlanta Journal-Constitution· 6 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
AstraZeneca to withdraw COVID-19 vaccine worldwide due to low demand
KOAA5· 6 days agoDrugmaker AstraZeneca is reportedly pulling its COVID-19 vaccine from global markets due to a...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoSales also tumbled 20% to $14.88 billion, but topped forecasts for $13.87 billion. As expected,...
AstraZeneca pulls its COVID-19 vaccine from Europe
Boston Herald· 5 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator....
Four ways the vaccine rush will define infectious disease trends for CROs in 2024
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe speed and flexibility required in clinical trials for COVID-19 set a new precedent for what can...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 5 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 4 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...